Defining the Communication Between Agonist and Coactivator Binding in the Retinoid X Receptor a Ligand Binding Domain
News Nov 06, 2013
Background: Some retinoid X receptor (RXR) agonists have potential as cancer drugs.
Results: Structures of RXR in complex with two different agonists show similar folds. Dynamics analysis reveals unique ligand-induced dynamics in helices 3, 11, and 12.
Conclusion: Two networks of interactions which connect RXR agonists to coactivator binding are defined.
Significance: Recognizing common conformational changes and distinguishing dynamics of RXR-selective agonists is needed for advances in drug design.
This article was published online in The Journal of Biological Chemistry and is free to access.
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Structure of Amino Acid Transporter Involved in Cancer RevealedNews
The human glutamine transporter ASCT2 is upregulated in several forms of cancer. It is also the docking platform for a wide range of pathogenic retroviruses. A team of University of Groningen scientists have used cryo-electron microscopy to elucidate the structure of the protein, which may generate leads for drug development.READ MORE